Novel compound heterozygous mutations of the FBP1 gene in a patient with hypoglycemia and lactic acidosis: A case report
Molecular Genetics & Genomic Medicine · 2024-01 · 12 (1)
DOI: 10.1002/mgg3.2339 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 19.12.2023. Verfasst von Bin Xin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Dalian Women and Children's Medical Group, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Acidosis, Lactic, Fructose-1,6-Diphosphatase Deficiency, Hypoglycemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalian Science and Technology Bureau.
Abstract (Originalsprache)
Background
Fructose‐1,6‐bisphosphatase (FBPase) deficiency, caused by an FBP1 mutation, is an autosomal recessively inherited metabolic disorder characterized by impaired gluconeogenesis. Due to the rarity of FBPase deficiency, the mechanism by which the mutations cause enzyme activity loss still remains unclear.
Methods
We report a pediatric patient with typical FBPase deficiency who presented with hypoglycemia, hyperlactatemia, metabolic acidosis, and hyperuricemia. Whole‐exome sequencing was used to search for pathogenic genes, Sanger sequencing was used for verification, and molecular dynamic simulation was used to evaluate how the novel mutation affects FBPase activity and structural stability.
Results
Direct and allele‐specific sequence analysis of the FBP1 gene (NM_000507) revealed that the proband had a compound heterozygote for the c. 490 (exon 4) G>A (p. G164S) and c. 861 (exon 7) C>A (p. Y287X, 52), which he inherited from his carrier parents. His father and mother had heterozygous G164S and Y287X mutations, respectively, without any symptoms of hypoglycemia.
Conclusion
Our results broaden the known mutational spectrum and possible clinical phenotype of FBP1 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Dalian Women and Children's Medical Group, Dalian, Liaoning, China.
- College of Pharmacy, Dalian Medical University, Dalian, Liaoning, China.
- Department of Emergency Medicine, Dalian Women and Children's Medical Group, Dalian, Liaoning, China.
ORCID-Profile: Bin Xin, Haiming Chen, Zhong Li
Förderung
- Dalian Science and Technology Bureau
Zitieren
APA
Xin, B., Chen, H., Liu, T., Wu, Y., Hu, Q., Dong, X., & Li, Z. (2024). Novel compound heterozygous mutations of the FBP1 gene in a patient with hypoglycemia and lactic acidosis: A case report. Molecular Genetics & Genomic Medicine, 12(1). https://doi.org/10.1002/mgg3.2339
Vancouver
Xin B, Chen H, Liu T, Wu Y, Hu Q, Dong X, et al. Novel compound heterozygous mutations of the FBP1 gene in a patient with hypoglycemia and lactic acidosis: A case report. Molecular Genetics & Genomic Medicine. 2024;12(1). doi:10.1002/mgg3.2339
BibTeX
@article{Xin2024,
author = {Xin, Bin and Chen, Haiming and Liu, Tianyi and Wu, Yue and Hu, Qingyang and Dong, Xue and Li, Zhong},
title = {Novel compound heterozygous mutations of the FBP1 gene in a patient with hypoglycemia and lactic acidosis: A case report},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
volume = {12},
number = {1},
doi = {10.1002/mgg3.2339}
}
EUVIMED